A retrospective study on the incidence and risk factors of severe hypoglycemia in primary care

Family Practice

Volumn 30, Issue 3, 2013, Pages 290-293

  Sämanna, Alexander ^a   Lehmann, Thomas ^a   Heller, Tabitha ^a   Müller, Nicolle ^a   Hartmann, Petra ^b   Wolf, Gunter B ^a   Müller, Ulrich A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Volkswagen Logistics   (Germany)

Author keywords

Diabetes mellitus; Primary care; Severe hypoglycemia

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

AGED; ARTICLE; BODY MASS; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GERMANY; HEALTH CARE; HEALTH INSURANCE; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY MEDICAL CARE; RISK FACTOR;

DIABETES MELLITUS; PRIMARY CARE; SEVERE HYPOGLYCEMIA.;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GERMANY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84878632884     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cms071     Document Type: Article

References (24)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabe-tes (UKPDS 33). Lancet 1998; 352: 837-53.
3. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-72.
4. Cryer PE. The barrier of hypoglycaemia in diabetes. Diabetes 2008; 57: 3169-76.
5. The Diabetes Control and Complications Research Group. Hypoglycaemia in the Diabetes Control and Complications Trial. Diabetes 1997; 46: 271-86.
6. Sämann A, Mühlhauser I, Bender R, Kloos CH, Müller UA. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study. Diabetologia 2005; 48: 1965-70.
7. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002; 325: 746.
8. Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R, Band MM, Reekie G, Leese GP. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med 2005; 22: 749-55.
9. U.K. Hypoglycaemia Study Group Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007; 50: 1140-7.
10. Bott S, Bott U, Berger M, Mühlhauser I. Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia 1997; 40: 926-32.
11. Mühlhauser I, Overmann H, Bender R, Bott U, Berger M: Risk factors of severe hypoglycaemia in adult patients with Type 1 diabetes - a prospective population based study. Diabetologia 1998; 41: 1274-82.
12. Amiel S: Hypoglycaemia: From the laboratory to the clinic. Diabetes Care 2009; 32: 1364-71.
13. Pedersen-Bjergaard U, Pramming S, Heller SR, Wallace TM, Rasmussen AK, Jørgensen HV, Matthews DR, Hougaard P, Thorsteinsson B. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 2004; 20: 479-86.
14. Holstein A, Plaschke A, Egberts E-H. Clinical characterization of severe hypoglycaemia: a prospective population-based study. Exp Clin Endocrinol Diabetes 2003; 111: 364-9.
15. Sämann A, Tajiyeva O, Müller N, Tschauner T, Hoyer H, Wolf G, Müller UA. Prevalence of the diabetic foot syndrome at the primary care level in Germany: a cross-sectional study. Diab Med 2008; 25: 557-63.
16. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-12.
17. R Development Core Team (2010). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org (accessed on 1 November 2012).
18. Müller N, Schiel R, Osterbrink B, Holl RW, Kerner W, Hauner H, Beyer P, Hoyer H, Krug J, Müller UA. Care and Outcome in Patients with Diabetes Mellitus Type 1 and Type 2 in Specialized Practice, Diabetes Specialized Hospital and Diabetes Department of a Regional General Hospital in Germany 2005. Diabetologie 2008; 3: 41-50.
19. Cryer PE. Are gender differences in the responses to hypoglycemia relevant to iatrogenic hypoglycemia in type 1 diabetes? Clin Endocrinol Metab 2000; 85:2145-7.
20. Parekh B. Mechanisms of the blunting of the sympatho-adrenal response: a theory. Curr Diabetes Rev 2009; 5: 79-91.
21. American Diabetes Association Workgroup on Hypoglycaemia: Defining and reporting hypoglycaemia in diabetes. Diabetes Care 2005; 28: 1245-9.
22. Schulze J, Rothe U, Müller G, Kunath H. [Improvement of care for diabetics using the care model from Saxony]. Dtsch Med Wochenschr 2003; 128: 1161-6.
23. Altenhofen L, Blaschy S, Hagen B, Haβ W, Kretschmann J. Qualitätssicherungsbericht 2006: Disease-Management- Programme in Nord-rhein. Herausgeber Nordrheinische Gemeinsame Einrichtung Disease-Management-Programme GbR, Düsseldorf. Nordrhein KV (ed). http://www.kvno.de/downloads/quali/qualbe_dmp06.pdf (accessed on 11 December 2011).
24. Baillargeon J. Characteristics of the healthy worker effect. Occup Med 2001; 16: 359-66.